Matthew Cortese, MD, MPH

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Abbvie, Inc.
    Topic: 
    CLL/SLL, Lymphomas
    Date added: 
    01/26/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Astra Zeneca, Inc
    Topic: 
    CLL/SLL, Lymphomas
    Date added: 
    01/26/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    ADC Therapeutics, Inc
    Topic: 
    CLL/SLL, Lymphomas
    Date added: 
    01/26/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Precision Oncology
    Topic: 
    CLL/SLL, Lymphomas
    Date added: 
    01/26/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Secura Bio, Inc
    Topic: 
    CLL/SLL, Lymphomas
    Date added: 
    01/26/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Cellectar Biosciences
    Topic: 
    LPL/WM, CNS lymphomas
    Date added: 
    01/26/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Synthekine
    Topic: 
    CLL/SLL, Lymphomas
    Date added: 
    01/26/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Curio Life Sciences
    Topic: 
    Hodgkin Lymphoma
    Date added: 
    01/26/2024
Return to Upstate New York Hematology & Hematologic Oncology Conference: Updates from the 65th ASH Annual Meeting